Moxetumomab pasudotox and Paclitaxel (Conventional)
Determining the interaction of Moxetumomab pasudotox and Paclitaxel (Conventional) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: paclitaxel
Brand name: Onxol, Taxol
Synonyms: Paclitaxel, PACLitaxel (Conventional)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Paclitaxel Concentrate Injection
- Moxetumomab pasudotox-Paclitaxel Intravenous
- Moxetumomab pasudotox-Paclitaxel Novaplus
- Moxetumomab pasudotox-Paclitaxel protein-bound
- Moxetumomab pasudotox-Paclitaxel protein-bound Intravenous
- Moxetumomab pasudotox-Pacnex
- Paclitaxel (Conventional)-Moxetumomab Pasudotox-tdfk
- Paclitaxel (Conventional)-Moxetumomab pasudotox-tdfk Intravenous
- Paclitaxel (Conventional)-Moxifloxacin
- Paclitaxel (Conventional)-Moxifloxacin (Systemic)
- Paclitaxel (Conventional)-Moxifloxacin Hydrochloride
- Paclitaxel (Conventional)-Moxifloxacin Injection